The reconstruction algorithm used for [68Ga]PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia.

about

The reconstruction algorithm used for [68Ga]PSMA-HBED-CC PET/CT reconstruction significantly influences the number of detected lymph node metastases and coeliac ganglia.

Item

http://www.wikidata.org/entity/Q39143896

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@en

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@nl

type

Item

label

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@en

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@nl

prefLabel

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@en

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@nl

P1476

The reconstruction algorithm u ...... etastases and coeliac ganglia.

@en

P2093

Anita Birmes

http://www.w3.org/2001/XMLSchema#string

Felix M Mottaghy

http://www.w3.org/2001/XMLSchema#string

Florian F Behrendt

http://www.w3.org/2001/XMLSchema#string

Frederik A Verburg

http://www.w3.org/2001/XMLSchema#string

Natascha I Drude

http://www.w3.org/2001/XMLSchema#string

Oliver H Winz

http://www.w3.org/2001/XMLSchema#string

Thomas Krohn

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

Benefit of time-of-flight in PET: experimental and clinical results.

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer.

Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.

Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with (68)Ga-PSMA-HBED-CC than with (18)F-Fluoroethylcholine PET/CT.

(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.

P2888

s00259-016-3571-6

P304

662-669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-016-3571-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27900518

http://www.w3.org/2001/XMLSchema#string